1. Researchers call out Gilead over diversity of remdesivir trials — Bristol-Myers commits $300M to combat racial disparities — Goldman predicts at least one coronavirus vaccine approval before the end of 2020 — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Precision Therapeutics

Anonymous Board for Precision Therapeutics

Sort By:
Title ↓
Replies Views
Last Message
  1. Anonymous
    Replies:
    3
    Views:
    2,747
  2. Anonymous
    Replies:
    3
    Views:
    2,746
  3. Anonymous
    Replies:
    5
    Views:
    2,333
  4. Anonymous
    Replies:
    0
    Views:
    2,258
  5. Anonymous
    Replies:
    9
    Views:
    3,316
  6. Anonymous
    Replies:
    28
    Views:
    6,571
  7. Anonymous
    Replies:
    2
    Views:
    2,960
  8. Anonymous
    Replies:
    2
    Views:
    2,616
  9. Anonymous
    Replies:
    5
    Views:
    3,201
  10. Anonymous
    Replies:
    22
    Views:
    6,890
  11. Anonymous
    Replies:
    0
    Views:
    2,168
  12. Anonymous
    Replies:
    13
    Views:
    2,769
  13. Anonymous
    Replies:
    1
    Views:
    5,016
  14. Anonymous
    Replies:
    2
    Views:
    2,957
  15. Anonymous
    Replies:
    11
    Views:
    5,822
  16. Anonymous
    Replies:
    2
    Views:
    2,168
  17. Anonymous
    Replies:
    5
    Views:
    3,967
  18. Anonymous
    Replies:
    1
    Views:
    1,880
  19. anonymous
    Replies:
    17
    Views:
    8,884
  20. Anonymous
    Replies:
    1
    Views:
    4,140

Thread Display Options

Loading...